Events on 27 September 2023

CONGRESS 2023 - Mismatch Repair (MMR): Ten years of EQA experience

27/09/2023
Delegates attending this presentation will:

Receive an overview of the clinical history of MMR/Lynch Syndrome, EQA and data from UK NEQAS ICC & ISH
Gain a better understanding of the importance of MMR testing and the UK NEQAS ICC & ISH assessment process.
The presentation will also focus on acceptable and not acceptable tests, and the importance of ideal controls.

CONGRESS 2023 - UK NEQAS ICC: PDL1 and EQA

27/09/2023
This presentation will focus on the PD-L1 clones used for the different indications, acceptable and not acceptable tests, and the importance of ideal controls.

Delegates attending this presentation will:

Receive an overview of PD-L1 EQA assessments carried out by UK NEQAS ICC & ISH
Gain a better understanding of the UK NEQAS PD-L1 schemes and how assessments are carried out.

CONGRESS 2023 - Troubleshooting specialist demonstration techniques

27/09/2023
This interactive presentation will discuss general demonstration techniques, troubleshooting, and how to make the best out of the feedback you receive from your UK NEQAS CPT Results reports. The content will also cover – how to manage SOPs, importance of understanding mechanisms of action and uses of stains, recording, monitoring, and trending of IQC failures and use of UK NEQAS CPT resources to help improve staining.

There will also be an opportunity for delegates to join in and score examples of stained slides against the UK NEQAS CPT assessment criteria.

CONGRESS 2023 - Reflection on a Journey from Trainee Biomedical Scientist to Consultant Clinical Scientist

27/09/2023
This presentation will give:

Training requirements for Biomedical Scientists and Clinical Scientists
Insight into how the skills of a Biomedical Scientist enabled development toward Consultant Clinical Scientist.

CONGRESS 2023 - Ovarian hyperstimulation syndrome (OHSS) – how does the clinical biochemistry laboratory inform clinical decisions?

27/09/2023
Ovarian Hyperstimulation Syndrome is one of the most dangerous complications associated with assisted conception using invitro fertilisation (IVF). If not managed appropriately it can even lead to death of the women developing ovarian hyperstimulation syndrome. Clinical Biochemistry aids significantly in the diagnosis and management of ovarian hyperstimulation syndrome.

This presentation aims to summarise the role of various biochemical parameters that are used routinely in the diagnosis and management of ovarian hyperstimulation syndrome.

CONGRESS 2023 - The role of a Regional Newborn Screening laboratory

27/09/2023
Newborn screening (NBS) is an essential public health strategy aimed at identifying newborn babies that are affected by certain genetic, metabolic and infectious conditions. NBS enables the early detection and management of several congenital disorders, which if left untreated, may lead to mental retardation and/or death. Early diagnosis and instigation of treatment, along with appropriate long-term care help ensure normal growth and development of the affected individual.

The Sheffield Regional NBS Laboratory is one of the largest newborn screening laboratories in the UK testing around 65,000 newborn bloodspot samples per year and has been an integral part of routine newborn care for the region of South Yorkshire, Lincolnshire and East Midlands. Newborn screening in the United Kingdom now includes screening for 10 conditions including multiple metabolic, haemoglobinopathies and only recently severe combined immunodeficiency - all detectable though multiplex laboratory procedures.

This presentation will briefly review the implementation of newborn screening in the region, including a brief history and justification for newborn screening, laboratory detection and diagnosis of the screening condition, the referral pathway/notification to a regional consultant paediatrician for initiation of treatment of the condition/follow up testing and conclude with a case study.

CONGRESS 2023 - Your career in Clinical Biochemistry: IBMS qualifications and the role of the Advisory Panel (Wednesday)

27/09/2023
Your career in Clinical Biochemistry: IBMS qualifications and the role of the Advisory Panel

CONGRESS 2023 - The metabolic role of Vitamin B12

27/09/2023
Delegates will understand:

The pathophysiological aspects of Vitamin B12.
The role of the laboratory in the diagnosis of Vitamin B12 deficiency.

CONGRESS 2023 - 2pm The metabolic role of Vitamin B12 Clinical Chemistry 2.30pm Lipid disorders Clinical Chemistry Lipid disorders

27/09/2023
This presentation will provide an update Update to the clinical use of lipids and the laboratory role in lipid disorders.

CONGRESS 2023 - Molar pregnancy and gestational trophoblastic disease – why the hCG assay matters

27/09/2023
In this presentation, Imran Jabbar, will delve into the crucial topic of measuring human chorionic gonadotrophin (hCG) in gestational trophoblastic disease (GTD). With a focus on trophoblastic tumours, Imran will explore the significance of hCG as a diagnostic and monitoring tool in GTD. The presentation will cover the principles behind hCG measurement techniques, including immunoassays and molecular methods.

Imran will highlight the challenges and advancements in accurately quantifying hCG levels, and discuss their clinical implications. Attendees will gain insights into the role of hCG measurement in early detection, disease monitoring, and prognostic evaluation, ultimately contributing to improved patient outcomes in GTD management.